|
Y-mAbs Therapeutics, Inc.
January 19, 2023 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) stock. A complaint has been filed on behalf of investors who purchased shares of Y-mAbs common stock on the open market, or pursuant to Registration Statements filed with the U.S. Securities and Exchange Commission (“SEC”), during the period October 6, 2020 through October 28, 2022, inclusive (the “Class Period”).
|
|
Daktronics, Inc.
January 18, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQ: DAKT). A complaint has been filed on behalf of investors who purchased or otherwise acquired Daktronics securities between March 10, 2022 and December 6, 2022, inclusive (the “Class Period”). Click Here to Join Investigation.
|
|
Sunlight Financial Holdings Inc.
January 18, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sunlight Financial Holdings Inc. (“Sunlight” or the “Company”) (NYSE: SUNL). A complaint has been filed on behalf of investors who purchased or otherwise acquired Sunlight securities between January 25, 2021 and September 28, 2022, inclusive (the “Class Period”). Click Here to Join Investigation.
|
|
NRIA Partners Portfolio Fund I LLC
January 18, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in the NRIA Partners Portfolio Fund I LLC (the “NRIA Fund”). A complaint has been filed on behalf of investors who purchased “membership units” in the NRIA Fund from at least February 2018 through January 2022 (the “Class Period”). Click Here to Join Investigation.
|
|
Bioventus Inc.
January 18, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS). A complaint has been filed on behalf of investors who purchased or otherwise acquired Bioventus securities traceable to the Company’s initial public offering conducted on or about February 11, 2021 (the “IPO”) and/or Bioventus securities between February 11, 2021 and November 21, 2022, inclusive (the “Class Period”). Click here to join investigation.
|
|
Enovix, Corp.
January 18, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Enovix Corp. (“Enovix” or “Company”) (NASDAQ: ENVX) f/k/a Rodgers Silicon Valley Acquisition Corp. (“RSVAC”) (NASDAQ: RSVAU). A complaint has been filed on behalf of investors who purchased or otherwise acquired Enovix or RSVAC common stock between February 22, 2021 and January 3, 2023, inclusive (the “Class Period”). Click here to join investigation.
|
|
Southwest Airlines Co
January 6, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Southwest Airlines Co. (“Southwest” or “Company”) (NYSE: LUV). Click here to join investigation.
|
|
Silvergate Capital Corporation
January 5, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Silvergate Capital Corp. (“Silvergate” or “Company”) (NYSE: SI). Click here to join investigation.
|
|
Genesis Global Capital
December 19, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of customers of Genesis Global Capital, LLC, including users of Gemini Trust Company, LLC’s (“Gemini”) Earn program.
|
|
Singularity Future Technology Ltd
December 12, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors of Singularity Future Technology Ltd ("Singularity” or the "Company") (NASDAQ: SGLY).
|
|
G-III Apparel Group Ltd.
December 1, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of G-III Apparel Group Ltd. (“G-III” or “Company”) (NASDAQ: GIII). Click here to contact us.
|
|
Olaplex Holdings, Inc.
November 29, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Olaplex Holdings, Inc. (NASDAQ: OLPX), a company that manufactures and sells hair care products. A class action complaint has been filed on behalf of investors that purchased or otherwise acquired Olaplex common stock pursuant and/or traceable to the Company’s September 30, 2021 initial public offering (“IPO”).
|
|
Provident Bancorp, Inc.
November 25, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Provident Bancorp, Inc. (“Provident” or “Company”) (NASDAQ: PVBC).
|
|
Bioventus Inc.
November 17, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bioventus Inc. (“Bioventus”) (NASDAQ: BVS).
|
|
Vintage Wine Estates, Inc.
November 17, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vintage Wine Estates, Inc. (NASDAQ: VWE, VWEWW). A class action complaint has been filed on behalf of investors that purchased or otherwise acquired Vintage Wine Estates securities between October 13, 2021 and September 13, 2022.
|
|
Olo, Inc.
November 17, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is reminding shareholders that a class action complaint was filed on behalf of investors of Olo Inc. ("Olo” or the "Company”) (NYSE: OLO), a company that provides an on-demand digital commerce platform for multi-location restaurant brands.
|
|
Compass Minerals International, Inc.
November 17, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is reminding shareholders that a class action lawsuit was filed against Compass Minerals International, Inc. ("Compass" or "the Company") (NYSE: CMP) on behalf of purchasers of Compass common stock between October 31, 2017 and November 18, 2018, inclusive (the “Class Period”) for violations of the federal securities laws. Compass mines and produces essential minerals, including salt for winter roadway safety and other consumer, industrial, and agricultural uses, and specialty plant nutrition minerals that improve the quality and yield of crops.
|
|
DLocal Limited
November 16, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DLocal Limited (“DLocal”) (NASDAQ: DLO).
|
|
FIGS Inc.
November 16, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FIGS Inc. (NYSE: FIGS). A class action complaint has been filed on behalf of investors that purchased or otherwise acquired FIGS securities between May 27, 2021 and May 12, 2022 and/or FIGS stock pursuant and/or traceable to FIGS’ initial public offering (the “IPO”).
|
|
Bird Global, Inc.
November 15, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bird Global, Inc. (“Bird” or “Company”) (NYSE: BRDS).
|
|
Rent the Runway
November 15, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Rent the Runway, Inc. (“Rent the Runway” or “Company”) (NASDAQ: RENT). A class action complaint has been filed on behalf of purchasers of Rent the Runway Class A common stock in or traceable to the Company’s October 27, 2021 initial public offering (“IPO”).
|
|
Twist Bioscience Corp.
November 15, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST).
|
|
Freshworks Inc.
November 10, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Freshworks Inc. (NASDAQ: FRSH). A class action complaint has been filed on behalf of investors that purchased or otherwise acquired Freshworks common stock pursuant and/or traceable to the Company’s September 2021 initial public offering (the “IPO”).
|
|
FTX
November 10, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims concerning the crypto exchange platform FTX Trading LTD d/b/a FTX, FTX US, their founder and CEO Sam Bankman-Fried, and Alameda Research, a related party cryptocurrency trading firm.
|
|
Fulgent Genetics, Inc.
November 9, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) and that November 21, 2022 is the deadline for seeking appointment as lead plaintiff.
|
|
Unisys Corporation
November 8, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Unisys Corporation (“Unisys” or the “Company”) (NASDAQ: UIS).
|
|
Spectrum Pharmaceuticals, Inc.
November 3, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI) securities.
|
|
Polished.com
November 2, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Polished.com Inc. f/k/a 1847 Goedeker Inc. (“Polished.com” or the "Company”) (NYSE American: POL; GOED). A class action complaint has been filed on behalf of investors that purchased or otherwise acquired Polished.com securities pursuant or traceable to the Company’s Registration Statement for its July 2020 initial public offering (“IPO”) or purchased Polished.com securities between July 27, 2020 and August 26, 2022 (the “Class Period”).
|
|
Rite Aid Corporation
October 26, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Rite Aid Corporation (“Rite Aid” or the "Company”) (NYSE: RAD). A class action complaint has been filed on behalf of investors that purchased or otherwise acquired Rite Aid securities between April 14, 2022 and September 28, 2022, inclusive (the “Class Period”).
|
|
Bed Bath and Beyond Inc.
October 24, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bed Bath & Beyond Inc. ("Bed Bath & Beyond” or the "Company”) (NASDAQ: BBBY).
|
